Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, THC Therapeutics's Enterprise Value is $0.76 Mil.
THC Therapeutics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jul. 2024 was $-0.18 Mil. Therefore, THC Therapeutics's EV-to-OCF for today is -4.13.
The historical rank and industry rank for THC Therapeutics's EV-to-OCF or its related term are showing as below:
THCT'
s EV-to-OCF Range Over the Past 10 Years
Min: -25.38 Med: 0 Max: 0
Current: -4.13
THCT's EV-to-OCF is not ranked
in the Drug Manufacturers industry.
Industry Median: 10.725
vs THCT: -4.13
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
THC Therapeutics's PE Ratio (TTM) for today is calculated as:
THC Therapeutics's share price for today is $0.0006.
THC Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.066.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
THC Therapeutics EV-to-OCF Related Terms
THC Therapeutics EV-to-OCF Historical Data
* Premium members only.
The historical data trend for THC Therapeutics's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
THC Therapeutics EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where THC Therapeutics's EV-to-OCF falls into.
THC Therapeutics's current Enterprise Value is $0.76 Mil.
THC Therapeutics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
THC Therapeutics (THCT) has a EV-to-OCF of -4.13 as of Aug. 03, 2026.
Is THC Therapeutics' EV-to-OCF too high?
THC Therapeutics' current EV-to-OCF is -4.13.
How does THC Therapeutics' EV-to-OCF compare to ZTS and UTHR?
THC Therapeutics' EV-to-OCF of -4.13 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-OCF is 10.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.73, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. THC Therapeutics's current EV-to-OCF is -4.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Therapeutics stock overvalued right now?
THC Therapeutics (THCT) has a current EV-to-OCF of -4.13. The current EV-to-OCF is -4.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For THC Therapeutics (THCT), the current EV-to-OCF is -4.13 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
THCT has been successfully added to your 
